In May 2019, a trial at Nanjing College Medical center commenced comparing dapagliflozin to liraglutide, also to the anti-diabetic medication acarbose, for their respective results on cognitive and olfactory functionality in 87 overweight men and women whose Type 2 diabetes is inadequately managed with metformin by itself. Stick to all https://richardy244tfq7.wikinewspaper.com/user